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Abstract 
 
Background 
Mastoid surgery carried out to treat chronic otitis media (COM) can lead to an improvement 
in objective and subjective measures post-operatively. This study aims to look at the 
subjective change in quality of life using the Glasgow Benefit Inventory relative to the type 
of mastoid surgery undertaken. 
Method 
A retrospective multi-centre postal questionnaire survey of 157 patients who underwent 
mastoid surgery from 2008-2012.  
Results 
83 questionnaire responses were received from patients having the surgery at 3 different 
hospitals (a response rate of 53%).  
57% of patients had a Glasgow benefit Score of 0 indicating no change in quality of life post-
operatively. 35% scored +50 indicating a significant improvement. The only significant 
difference found was that women fare worse after surgery than men.  
Conclusions 
The choice of mastoid surgery technique should be determined by clinical need and surgeon 
preference. There is no improvement in quality of life for most patients. 
 
Key Words: mastoid, surgery, quality of life 
 
 
 
 
INTRODUCTION 
Mastoid surgery is performed to treat both mucosal and squamous chronic otitis media 
(COM) with the primary aim to give a dry, healthy and stable ear, however any hearing 
improvement is also welcome. Objective measures of successful surgery are easy to 
evaluate; for example, cessation of otorrhoea and improvement in hearing. However, the 
disease also has a significant impact on a patient’s quality of life. In addition to the physical 
burden of the disease, there are other factors to consider. These include repeated hospital 
visits, the application of multiple courses of topical medication, poor communication due to 
reduced hearing and its impact on a patient’s social and professional interactions, as well as 
the psychological impact of a foul smelling ear. The literature reports an improvement in 
patients’ quality of life post-operatively1,2,3. This study takes a closer look at post-operative 
quality of life relative to the type of surgery performed, in particular comparing canal-wall-
up versus canal-wall down surgery, using the Glasgow Benefit Inventory, a validated tool for 
assessing ear symptoms. 
 
METHOD 
Participants and recruitment 
Adults undergoing mastoid surgery from 2008-2012 were included in the study. The patients 
were chosen consecutively using theatre logs to identify them. The surgery was performed 
by three consultants and their specialist registrars at one of three Ear, Nose & throat (ENT) 
departments in the South-East of England (Southend University Hospital, Whipps Cross 
University Hospital and the Royal National Throat, Nose & Ear Hospital). Surgery was carried  
out for mucosal or squamous chroic otitis media (COM).  
Local research and development approval was obtained without the requirement for ethical 
approval. 
 
Measures 
Primary outcome 
We performed a multicentre retrospective quality of life survey. The Glasgow Benefit 
Inventory (GBI) questionnaire was posted to 157 patients. The GBI is an 18-item validated 
tool for measuring outcomes after ENT surgical procedures4. It measures quality of life in 
three domains: social, physical and general. Each question is based on a five point Likert 
scale; where 5 denotes the most favorable outcome, and 1, the poorest results, whereas a 
response of 3 denotes no change. The average Likert score for the whole questionnaire is 
calculated. This then has 3 subtracted from it (no change) and the result is multiplied by 50. 
The resultant score ranges from -100 (maximum detriment after surgery) to +100 (maximum 
improvement after surgery). A score of zero indicates no change in quality of life following 
the intervention.  
 
Predictors and participant characteristics 
The main predictor was type of surgery. This was collected from theatre logs and confirmed 
by reviewing the patient notes. 
The following were potential covariates: 
 Disease type - Mucosal or squamous COM. 
 Disease stage - The following classification system for COM, adapted from the 
staging of middle ear cholesteatoma proposed by the Japan Otological Society5: 
Grade 1 - Disease limited to the mesotympanum/hypotympanum. Grade 2 - 
epitympanic involvement. Grade 3 - extension to the mastoid antrum. Grade 4 - 
extension beyond the mastoid antrum. 
 Disease location - Left or right 
 Grade of operating surgeon 
 Hospital site  
 Primary or revision surgery. 
 Age  
 Gender  
These were all recorded from the medical records.  
 
Sample size 
Our sample size was calculated to detect a medium effect size (w = 0.30) with alpha = 0.05 
and power = 0.80 between two groups – combined approach tympanoplasty (CAT) surgery 
vs. other (df=1).  A total sample size of 88 was required. This calculation was done using the 
software G*Power version 3.1. 
 
Statistical Analysis 
Logistic regression was used to examine univariate and multivariate predictors of surgical 
outcome (‘worse’ or ‘the same’ vs ‘better’) using the statistical package SPSS version 20. The 
categories ‘worse’ and ‘the same’ were combined because only a small number of people 
reported a worse outcome following surgery. 
 
Results  
83 questionnaire responses were received from patients having the surgery at 3 different 
hospitals (a response rate of 53% [83/157]). Response rate was not significantly associated 
with either gender (OR: 1.031; 95% CI: 0.541 to 1.965; p=0.927) or hospital site 
(Wald=3.268, df=2, p=0.195), but was significantly associated with age, with a higher 
response rate from older patients (OR: 1.044; 95% CI: 1.024 to 1.065; p<0.001; average age 
among responders vs. non-responders of 45 vs. 31 years). The demographic and clinical 
characteristics of responders are shown in Table 1; 31 (37%) at Southend University Hospital 
(SUH), 21 (25%) at Whipps Cross University Hospital (WXUH) and 31 (37%) at the Royal 
National Throat, Nose and Ear Hospital (RNTNEH). The average age was 44.5 (range from 15 
to 76) with 61% being male. 
 
All the operations at RNTNEH (31) were performed by a consultant and were always a 
combined approach tympanoplasty (CAT), whether as a primary or revision procedure. This 
technique was never performed at WXUH and only twice at SUH (total 33). In these latter 2 
centres modified radical mastoidectomy (MRM) was performed on 24 patients, 16 patients 
had atticotomy/atticoantrostomy, 9 patients had a cortical mastoidectomy, and 1 had a 
mastoid exploration and obliteration.  
 
63 (76%) operations were carried out by consultants and 20 (24%) by specialist registrars. In 
59 (71%) cases cholesteatoma was found, with the other 24 (29%) cases showing evidence 
of mucosal chronic otitis media (COM). 58 (70%) cases were primary procedures and 25 
(30%) cases were revisions, of which 3 were the second revision and 3 were the third 
revision. In 12 of the revision cases, cholesteatoma was present. 
 
The average Glasgow benefit score was 14.2. The overall scores for the patients were 
categorized into the following groups: -100, -50, 0, +50 or 100. A score within (+/-) 25 of 
each category led to the assignment into each group.  47 (57%) patients scored 0 indicating 
no overall benefit as a result of the surgery. 29 (35%) patients scored +50 indicating a 
significant benefit, 6 (7%) scored -50 indicating a significant deterioration following surgery, 
and 1 (1%) patient scored +100 indicating excellent improvement with no negative 
consequences at all. The Glasgow benefit score following each individual procedure is 
shown in Table 1. 
The patient who had a mastoid exploration and obliteration scored +50. 
 
There were no significant associations between the outcome of surgery and any of the other 
variables examined such as surgery type, disease type or disease stage (see Table 2). When 
the Glasgow benefit score is broken down into its different subscales, the physical subscale 
showed a non-significant trend towards greater improvement in the canal wall down groups 
versus the CAT group (p=0.061). However a Bonferroni correction due to multiple 
comparisons (i.e. group difference on the three subscales) means a p value of 0.02 would 
need to be observed for the difference to be considered significant. In addition, inspection 
of the means and standard deviations for the physical subscale across the two groups (CAT 
vs. other type of surgery) shows the difference was less than 0.5 of a standard deviation, 
which is considered the minimal important clinical difference (MID).  
 
The only significant finding in the statistical analysis was that women fare worse after 
surgery than men (OR: 0.260; 95% CI: 0.091-0.738; p=0.011). Women were more likely to 
have revision surgery but there were still significant gender differences when this (OR: 
0.302; 95% CI: 0.103-0.886; p=0.029), and when all of the other variables shown in Table 2 
were entered into the analysis (OR: 0.216; 95% CI: 0.063-0.744; p=0.015).  
 
Discussion 
Chronic otitis media (COM) carries a significant burden of disease for many sufferers. In 
those who do not respond to conservative and medical treatments, or who have active 
squamous disease, surgical treatment is often recommended. Broadly speaking, surgical 
options include canal-wall-up surgery or canal-wall-down surgery with or without primary 
bony obliteration. It has been shown that there are no significant differences in hearing 
outcomes between the techniques in COM patients6. However, there is great debate over 
the relative benefits of these techniques. These include the effectiveness of disease 
eradication, the need for further surgery, the frequency of aural toileting required and 
hearing outcomes.  
A complication rate of 28% following mastoid surgery has been found with the most 
common one being residual or recurrent disease. Most of the other complications such as 
meatal stenosis, moist cavity and tympanic membrane perforation occur within the first 6 
months. Regular outpatient attendance can prevent these complications or pick them up 
early so they can be treated.7 
Both canal wall up and canal wall down mastoidectomy is felt to be a safe operation even in 
the only hearing ear. At 48 months, 79% of patients were shown to have stable or improved 
hearing thresholds.8 
We present the first study comparing patient reported outcomes following different surgical 
techniques for mastoid surgery. 
The average Glasgow Benefit Inventory (GBI) score was calculated as 14.2. This correlates 
well with the large scale quality of life outcomes study in Scotland by Swan et al9 which gave 
an average GBI score of 13.8 for patients undergoing surgical treatment. They also showed a 
significant gain in the Health Utilities Index mark 3 (HUI-3) score for surgical treatment of 
active middle ear disease (+0.156) and inactive middle ear disease (+0.139). The HUI-3 is a 
generic questionnaire widely used in health economic evaluations across all domains of 
healthcare.  
Dornhoffer et al1 found an average post-operative GBI score of 28.9. This correlated well 
with hearing outcomes and levels of ear discharge. However, the cohort of patients studied 
were all revision cases undergoing mastoid exploration and obliteration. 
Merchant et al2 investigated a similar cohort of patients to our study with larger numbers 
(272 patients). The only outcome they recorded was control of infection with an overall 
success rate of 95%. As in our study, they found no difference between the type of surgery, 
extent of disease or whether the surgery was primary or revision. However patients with 
cholesteatoma fared better than those with just granulation tissue. This difference, as well 
as the gender differences in our study, could be explained by the fact that we used a 
subjective outcome questionnaire, whereas Merchant et al used clinical examination as the 
outcome measure. 
A cost utility analysis of tympanomastoid surgery has been carried out. It was found to be a 
cost-effective treatment, particularly in discharging ears3. This aspect of mastoid surgery 
was not explored in our study.  
The surgical aims of creating a safe and dry ear, by eradicating squamous disease, will 
frequently not be perceived by the patient. It is the prevention of future disease-related 
morbidity that is often the motivation for mastoid surgery in the presence of 
cholesteatoma. This helps explains the low GBI score reported in our study compared to 
surgical interventions in other specialties8.  
This study is also limited by relatively small numbers, although we have shown that there is 
adequate power to detect a large effect size.  
While others have found improved health related quality of life using the chronic ear survey 
(CES) questionnaire in the surgically managed COM, they also note other independent 
factors associated with worse outcomes. These include occurrence of complications, 
diabetes mellitus, a high level of education and low post-operative air conduction 
thresholds.10 
Surgical technique, disease stage and disease type has no impact on patient reported quality 
of life as indicated by the Glasgow Benefit Score responses we received. A non-significant 
trend towards improvement in the canal wall down group for the physical subscale was 
found. Greater numbers may have led to a significant finding in this subscale of the GBI.  
The implication of this is that the surgeon should not feel constrained towards a particular 
type of operation in order to treat COM due to perceived improved outcomes. The surgeon 
should choose the technique which they feel is most appropriate for the patient in view of 
disease stage, co-morbidities and follow up requirements. The lack of a significant 
difference in outcome between disease types and stages suggests that in general an 
appropriate operation has been performed. This also supports the view that the surgeon 
should choose the technique he/she feels most comfortable with and is most appropriate 
for each case.  
There is no clear explanation for the poorer outcomes in women compared to men. COM as 
a disease process shows no predilection for either gender; and the Glasgow benefit score is 
validated for both sexes.  The increased revision rate in women in this series correlates with 
poorer patient reported outcomes. This effect is most likely to be due to the relatively small 
numbers in this study, although it could also represent a differing impact of COM and 
mastoid surgery, along with a difference in expectations, between the sexes.  
 
Further work with increased patient numbers would provide more information. 
 
Summary 
 Chronic otitis Media (COM) as a disease entity causes significant morbidity and 
occasional mortality. 
  Treatment is surgical but patient reported outcomes show minimal changes in 
quality of life. 
 There have been no studies showing patient reported outcomes that compare 
different surgical techniques to treat this disease.  
 This study indicates that differing surgical techniques do not produce significantly 
different quality of life outcomes measured using the Glasgow Benefit Inventory 
(GBI) score. 
 Disease type and stage also does not affect outcome; however women showed 
significantly poorer scores post-operatively. 
 Surgical technique should be determined by the extent of disease, patient co-
morbidities and follow up requirements and operator choice.  
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Table 1: Demographic and clinical characteristics of the sample: overall and by quality of life 
  Glasgow benefit score 
 Overall Worse No change Better 
Age (mean and SD) 44.5 (16.7) 45.5 (13.7) 44.8 (18.1) 44.0 (15.4) 
Gender (%)     
Male 61.4 (n=51) 5.9 (n=3) 47.1 (n=24) 47.1 (n=24) 
Female 38.6 (n=32) 9.4 (n=3) 71.9 (n=23) 18.8 (n=6) 
Disease (%)     
Cholesteatoma 71.1 (n=59) 4.2 (n=1) 58.3 (n=14) 37.5 (n=9) 
Non cholesteatoma, 
NCSOM or retraction 
pocket 
28.9 (n=24) 8.5 (n=5) 55.9 (n=33) 35.6 (n=21) 
Disease stage 
0 
1 
2 
3 
4 
 
4.8 (n=4) 
25.3 (n=21) 
22.9 (n=19) 
19.3 (n=16) 
27.7 (n=23) 
 
0 (n=0) 
4.8 (n=1) 
0 (n=0) 
6.2 (n=1) 
17.4 (n=4) 
 
75.0 (n=3) 
57.1 (n=12) 
68.4 (n=13) 
56.2 (n=9) 
43.5 (n=10) 
 
25.0 (n=1) 
38.1 (n=8) 
31.6 (n=6) 
37.5 (n=6) 
39.1 (n=9) 
Side (%)     
Left 51.8 (n=43) 2.3 (n=1) 67.4 (n=29) 30.2 (n=13) 
Right 48.2 (n=40) 12.5 (n=5) 45.0 (n=18) 42.5 (n=17) 
Grade (%)     
Specialist registrar 24.1 (n=20) 5.0 (n=1) 45.0 (n=9) 50.0 (n=10) 
Consultant 75.9 (n=63) 7.9 (n=5) 60.3 (n=38) 31.7 (n=20) 
Hospital site (%)     
RNTNE 37.3 (n=31) 6.5 (n=2) 58.1 (n=18) 35.5 (n=11) 
SUH 37.3 (n=31) 6.5 (n=2) 67.7 (n=21) 25.8 (n=8) 
WX 25.3 (n=21) 9.5 (n=2) 38.1 (n=8) 52.4 (n=11) 
Type of surgery (%)     
Atticotomy or 
atticoantrostomy 
19.3 (n=16) 6.2 (n=1) 56.2 (n=9) 37.5 (n=6) 
Any type of CAT 39.8 (n=33) 6.1 (n=2) 57.6 (n=19) 36.4 (n=12) 
MRM or radical mastoid 28.9 (n=24) 8.3 (n=2) 58.3 (n=14) 33.3 (n=8) 
Cortical and mastoid 
obliteration 
12.0 (n=10) 10.0 (n=1) 50.0 (n=5) 40.0 (n=4) 
Revision surgery (%)     
No 69.5 (n=57) 3.5 (n=2) 56.1 (n=32) 40.4 (n=23) 
Yes 30.5 (n=25) 16.0 (n=4) 60.0 (n=15) 24.0 (n=6) 
 
Table 2: Univariate predictors of outcome of surgery: worse or no change vs. better (odds 
ratios and 95% confidence intervals) 
Demographics Univariate associations 
Gender  
Male:  
Female: 
 
[1.00] 
0.260 (0.091-0.738); p=0.011 
Age 0.997 (0.970-1.024) 
Disease characteristics  
Disease  
Cholesteatoma:  
Other (e.g. NCSOM): 
 
[1.00] 
1.086 (0.406-2.902) 
Disease stage  
Stage 0 or 1: 
Stage 2:  
Stage 3:  
Stage 4: 
 
[1.00] 
0.821 (0.231-2.910) 
1.067 (0.291-3.916) 
1.143 (0.355-3.681) 
Side  
Left:  
Right: 
 
[1.00] 
1.706 (0.691-4.211) 
Surgery  
Grade  
Consultant:  
Specialist registrar: 
 
[1.00] 
2.150 (0.772-5.990) 
Hospital site  
RNTNE:  
SUH:  
WX:  
 
[1.00] 
0.632 (0.213-1.881) 
2.000 (0.647-6.185) 
Type of surgery 
CAT:  
Atticotomy/ Atticoantrostomy: 
MRM:  
Obliteration:  
 
[1.00] 
1.050 (0.305-3.614) 
0.875 (0.290-2.645) 
1.167 (0.274-4.976) 
Type of surgery 
CAT:  
Non-CAT (Atticotomy/ 
Atticoantrostomy, MRM, 
 
[1.00] 
0.984 (0.394-2.457) 
 
Obliteration) 
Revision surgery 
No:  
Yes:  
 
[1.00] 
0.467 (0.162-1.347) 
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